Latest Insider Transactions at Liberty Latin America Ltd. (LILA)
This section provides a real-time view of insider transactions for Liberty Latin America Ltd. (LILA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Liberty Latin America Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Liberty Latin America Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2022
|
Balan Nair President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
251,174
-8.58%
|
$2,260,566
$9.62 P/Share
|
|
Mar 15
2022
|
Balan Nair President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
205,801
+9.35%
|
-
|
|
Mar 15
2022
|
Balan Nair President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
99,911
+8.35%
|
-
|
|
Mar 15
2022
|
Balan Nair President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
176,840
+15.47%
|
-
|
|
Mar 15
2022
|
Balan Nair President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
88,420
+16.04%
|
-
|
|
Mar 15
2022
|
Charles H R Bracken Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,174
+13.72%
|
-
|
|
Mar 15
2022
|
Charles H R Bracken Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,587
+17.28%
|
-
|
|
Mar 15
2022
|
Rocio Lorenzo CCO |
BUY
Grant, award, or other acquisition
|
Direct |
38,866
+50.0%
|
-
|
|
Mar 15
2022
|
Rocio Lorenzo CCO |
BUY
Grant, award, or other acquisition
|
Direct |
19,433
+50.0%
|
-
|
|
Mar 15
2022
|
John M Winter SVP, CLO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
25,765
-5.32%
|
$231,885
$9.62 P/Share
|
|
Mar 15
2022
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
46,752
+11.97%
|
-
|
|
Mar 15
2022
|
John M Winter SVP, CLO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
15,628
-6.28%
|
$140,652
$9.68 P/Share
|
|
Mar 15
2022
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
22,802
+11.61%
|
-
|
|
Mar 15
2022
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
38,866
+20.56%
|
-
|
|
Mar 15
2022
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
19,433
+20.09%
|
-
|
|
Mar 15
2022
|
Paul A Gould Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,076
+0.36%
|
-
|
|
Mar 15
2022
|
Paul A Gould Director |
BUY
Exercise of conversion of derivative security
|
Direct |
538
+0.37%
|
-
|
|
Mar 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9,939
-6.62%
|
$89,451
$9.62 P/Share
|
|
Mar 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
17,416
+13.57%
|
-
|
|
Mar 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,747
-6.59%
|
$42,723
$9.68 P/Share
|
|
Mar 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,455
+13.72%
|
-
|
|
Mar 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
15,926
+25.55%
|
-
|
|
Mar 15
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,962
+26.39%
|
-
|
|
Mar 15
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
36,091
-3.85%
|
$324,819
$9.62 P/Share
|
|
Mar 15
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
57,057
+8.11%
|
-
|
|
Mar 15
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
19,524
-4.32%
|
$175,716
$9.68 P/Share
|
|
Mar 15
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
27,839
+8.23%
|
-
|
|
Mar 15
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
50,526
+14.48%
|
-
|
|
Mar 15
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,263
+14.9%
|
-
|
|
Mar 15
2022
|
Michael T Fries Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
10,733
-2.52%
|
$96,597
$9.62 P/Share
|
|
Mar 15
2022
|
Michael T Fries Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,716
+5.05%
|
-
|
|
Mar 15
2022
|
Michael T Fries Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
4,987
-2.04%
|
$44,883
$9.68 P/Share
|
|
Mar 15
2022
|
Michael T Fries Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
11,358
+4.44%
|
-
|
|
Mar 01
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
405
-1.31%
|
$3,645
$9.66 P/Share
|
|
Mar 01
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,182
+3.69%
|
-
|
|
Mar 01
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
203
-1.41%
|
$1,827
$9.67 P/Share
|
|
Mar 01
2022
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
591
+3.93%
|
-
|
|
Mar 01
2022
|
Paul A Gould Director |
BUY
Open market or private purchase
|
Direct |
15,000
+9.31%
|
$135,000
$9.98 P/Share
|
|
Mar 01
2022
|
Balan Nair President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,816
-1.1%
|
$79,344
$9.66 P/Share
|
|
Mar 01
2022
|
Balan Nair President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,382
+1.65%
|
-
|
|
Mar 01
2022
|
Balan Nair President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,691
+1.76%
|
-
|
|
Mar 01
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,006
-0.4%
|
$9,054
$9.66 P/Share
|
|
Mar 01
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,940
+1.17%
|
-
|
|
Mar 01
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
503
-0.42%
|
$4,527
$9.67 P/Share
|
|
Mar 01
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,470
+1.21%
|
-
|
|
Mar 01
2022
|
John M Winter SVP, CLO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,308
-1.16%
|
$11,772
$9.66 P/Share
|
|
Mar 01
2022
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
3,824
+3.28%
|
-
|
|
Mar 01
2022
|
John M Winter SVP, CLO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
654
-1.12%
|
$5,886
$9.67 P/Share
|
|
Mar 01
2022
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
1,912
+3.16%
|
-
|
|
Feb 28
2022
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
14,537
-5.58%
|
$145,370
$10.09 P/Share
|